AI
Thursday, August 16, 2012 4:11:24 PM
PSTI. today. received permission from the Indian Ministry of Health to proceed with a Phase II clinical trial for the treatment of thromboangiitis obliterans (Buerger's disease).
http://ih.advfn.com/p.php?pid=nmona&article=53842049
8/13/12 Pluristem Moves Intermittent Claudication Indication Forward in Europe Through Collaboration With Cato Research
http://ih.advfn.com/p.php?pid=nmona&article=53794575
http://ih.advfn.com/p.php?pid=nmona&article=53842049
8/13/12 Pluristem Moves Intermittent Claudication Indication Forward in Europe Through Collaboration With Cato Research
http://ih.advfn.com/p.php?pid=nmona&article=53794575
5-Bagger contest on "Dawgg".
http://bit.ly/qthbYc
Sleepers!
http://bit.ly/Lbsa79
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
